Investors sold shares of Allergan PLC (NYSE:AGN) on strength during trading hours on Thursday. $123.68 million flowed into the stock on the tick-up and $141.79 million flowed out of the stock on the tick-down, for a money net flow of $18.11 million out of the stock. Of all equities tracked, Allergan PLC had the 0th highest net out-flow for the day. Allergan PLC traded up $3.22 for the day and closed at $237.76

A number of research analysts have recently commented on AGN shares. Piper Jaffray Cos. restated a “cautious” rating and set a $236.00 price target (down from $238.00) on shares of Allergan PLC in a research report on Wednesday, May 11th. Mizuho raised shares of Allergan PLC from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $248.00 to $318.00 in a report on Friday, August 19th. Vetr raised shares of Allergan PLC from a “buy” rating to a “strong-buy” rating and set a $288.87 price objective for the company in a report on Monday, August 22nd. Citigroup Inc. reaffirmed a “buy” rating and set a $285.00 price objective on shares of Allergan PLC in a report on Wednesday, May 11th. Finally, Wells Fargo & Co. reaffirmed a “buy” rating on shares of Allergan PLC in a report on Friday, June 10th. Six analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $309.13.

The stock’s 50-day moving average is $248.09 and its 200 day moving average is $247.61. The company has a market cap of $93.43 billion and a P/E ratio of 22.47.

Allergan PLC (NYSE:AGN) last issued its quarterly earnings data on Monday, August 8th. The company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.34 by $0.01. The business earned $3.68 billion during the quarter, compared to analysts’ expectations of $4.10 billion. The business’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the business earned $4.41 earnings per share. On average, equities analysts forecast that Allergan PLC will post $14.00 EPS for the current fiscal year.

A hedge fund recently raised its stake in Allergan PLC stock. Dimensional Fund Advisors LP raised its position in Allergan PLC (NYSE:AGN) by 6.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,596,389 shares of the company’s stock after buying an additional 103,314 shares during the period. Allergan PLC accounts for about 0.3% of Dimensional Fund Advisors LP’s holdings, making the stock its 28th largest position. Dimensional Fund Advisors LP owned approximately 0.41% of Allergan PLC worth $498,895,000 as of its most recent filing with the SEC.

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.